The DOI matches its Crossref record; 380 of the 380 references it cites were found in a registry or an index.
Complex Pharmacology of Free Fatty Acid Receptors
Open accessAbstract
G protein-coupled receptors (GPCRs) are historically the most successful family of drug targets. In recent times it has become clear that the pharmacology of these receptors is far more complex than previously imagined. Understanding of the pharmacological regulation of GPCRs now extends beyond simple competitive agonism or antagonism by ligands interacting with the orthosteric binding site of the receptor to incorporate concepts of allosteric agonism, allosteric modulation, signaling bias, constitutive activity, and inverse agonism. Herein, we consider how evolving concepts of GPCR pharmacology have shaped understanding of the complex pharmacology of receptors that recognize and are activated by nonesterified or "free" fatty acids (FFAs). The FFA family of receptors is a recently deorphanized set of GPCRs, the members of which are now receiving substantial interest as novel targets for the treatment of metabolic and inflammatory diseases. Further understanding of the complex pharmacology of these receptors will be critical to unlocking their ultimate therapeutic potential.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–380 of 380
Biased Signaling at Chemokine Receptors
Corbisier, J., Galès, C., Huszagh, A., Parmentier, M., & Springael, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.596098 · Cited by 121
GPCR structures in drug design, emerging opportunities with new structures
Tautermann, C. S. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.07.009 · Cited by 120
GPR40 is expressed in glucagon producing cells and affects glucagon secretion
Flodgren, E., Olde, B., Abaraviciene, S. M., Winzell, M. S., Åhrén, B., & Salehi, A. A. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.12.193 · Cited by 120
Tanaka, T., Yano, T., Adachi, T., Koshimizu, T., Hirasawa, A., & Tsujimoto, G. (2008) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0250-y · Cited by 120
Overview of trans fatty acids: Biochemistry and health effects
Bhardwaj, S., Passi, S. J., & Misra, A. (2011) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2012.03.002 · Cited by 119
Hudson, B. D., Due‐Hansen, M. E., Christiansen, E., Hansen, A. M., Mackenzie, A. E., Murdoch, H., Pandey, S. K., Ward, R. J., Márquez, R., Tikhonova, I. G., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.455337 · Cited by 118
Self-citationLack of FFAR1/GPR40 Does Not Protect Mice From High-Fat Diet–Induced Metabolic Disease
Hong, L., Hoos, L. M., Liu, L., Tetzloff, G. G., Hu, W., Abbondanzo, S. J., Vassileva, G., Gustafson, E. L., Hedrick, J. A., & Davis, H. R. (2008) · Diabetes · doi:10.2337/db08-0596 · Cited by 118
Lin, D. C.-H., Guo, Q., Luo, J., Zhang, J., Nguyen, K., Chen, M. J., Tran, T., Dransfield, P. J., Brown, S. P., Houze, J. B., et al. (2012) · Molecular Pharmacology · doi:10.1124/mol.112.079640 · Cited by 118
Martin, C., Passilly‐Degrace, P., Chevrot, M., Ancel, D., Sparks, S. M., Drucker, D. J., & Besnard, P. (2012) · Journal of Lipid Research · doi:10.1194/jlr.m025874 · Cited by 118
Rational design of dualsteric GPCR ligands: quests and promise
Mohr, K., Tränkle, C., Kostenis, E., Barocelli, E., Amici, M. D., & Holzgrabe, U. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00601.x · Cited by 117
β-Arrestin 2 Mediates G Protein-Coupled Receptor 43 Signals to Nuclear Factor-κB
Lee, S. U., In, H. J., Kwon, M. S., Park, B.-O., Jo, M., Kim, M.-O., Cho, S., Lee, S., Lee, H., Kwak, Y. S., et al. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00312 · Cited by 117
Existence of GPR40 functioning in a human breast cancer cell line, MCF-7
Yonezawa, T., Katoh, K., & Obara, Y. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.12.175 · Cited by 115
Pizzonero, M., Dupont, S., Babel, M., Beaumont, S., Bienvenu, N., Blanqué, R., Cherel, L., Christophe, T., Crescenzi, B., Lemos, E. D., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm5012885 · Cited by 113
The Prevalence, Maintenance, and Relevance of G Protein–Coupled Receptor Oligomerization
Milligan, G. (2013) · Molecular Pharmacology · doi:10.1124/mol.113.084780 · Cited by 112
Self-citationDuca, F. A., Swartz, T. D., Sakar, Y., & Covașă, M. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.45 · Cited by 111
Synthesis and activity of small molecule GPR40 agonists
Garrido, D. M., Corbett, D. F., Dwornik, K. A., Goetz, A. S., Littleton, T. R., McKeown, S. C., Mills, W. Y., Smalley, T. L. J., Briscoe, C. P., & Peat, A. J. (2006) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2006.01.007 · Cited by 111
Alteration of the Glucagon Axis in GPR120 (FFAR4) Knockout Mice
Suckow, A. T., Polidori, D., Yan, W., Chon, S., Jing, Y., Leonard, J. N., & Briscoe, C. P. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568683 · Cited by 110
Lu, X., Zhao, X., Feng, J., Liou, A. P., Anthony, S., Pechhold, S. B., Sun, Y., Lü, H., & Wank, S. A. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00541.2011 · Cited by 110
Functions of omega-3 fatty acids and FFA4 (GPR120) in macrophages
Im, D. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.094 · Cited by 108
Mustafi, D., & Palczewski, K. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.051938 · Cited by 108
Yousefi, S., Cooper, P. R., Potter, S., Mueck, B., & Járai, G. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.69.6.1045 · Cited by 107
Han, J., Kim, I., Jung, S., Lee, S.-G., Son, H., & Myung, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095268 · Cited by 107
Tomita, T., Masuzaki, H., Iwakura, H., Fujikura, J., Noguchi, M., Tanaka, T., Ebihara, K., Kawamura, J., Komoto, I., Kawaguchi, Y., et al. (2006) · Diabetologia · doi:10.1007/s00125-006-0193-8 · Cited by 107
GPR40 agonists for the treatment of type 2 diabetes: life after ‘TAKing’ a hit
Mancini, A. D., & Poitout, V. (2015) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12442 · Cited by 104
Defoßa, E., & Wagner, M. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.019 · Cited by 104
Identification of diarylsulfonamides as agonists of the free fatty acid receptor 4 (FFA4/GPR120)
Sparks, S. M., Chen, G., Collins, J. L., Danger, D. P., Dock, S. T., Jayawickreme, C. K., Jenkinson, S. G., Laudeman, C. P., Leesnitzer, M. A., Liang, X., et al. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.05.012 · Cited by 103
Omega 3 Fatty Acids and GPR120
Oh, D. Y., & Olefsky, J. M. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.009 · Cited by 103
Liu, Z., Hopkins, M. M., Zhang, Z., Quisenberry, C. B., Fix, L. C., Galvan, B. M., & Meier, K. E. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218974 · Cited by 103
Christensen, L. W., Kuhre, R. E., Janus, C., Svendsen, B., & Holst, J. J. (2015) · Physiological Reports · doi:10.14814/phy2.12551 · Cited by 102
The role of polyunsaturated fatty acids and GPR40 receptor in brain
Khan, M. Z., & He, L. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.05.013 · Cited by 101
β-Arrestin Recruitment and Biased Agonism at Free Fatty Acid Receptor 1
Mancini, A. D., Bertrand, G., Vivot, K., Carpentier, É., Tremblay, C. C., Ghislain, J. J., Bouvier, M., & Poitout, V. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.644450 · Cited by 101
G-protein coupled receptors mediating long chain fatty acid signalling in the pancreatic beta-cell
Morgan, N. G., & Dhayal, S. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.07.020 · Cited by 101
Identification of G protein-coupled receptor 120-selective agonists derived from PPARγ agonists
Suzuki, T., Igari, S.-I., Hirasawa, A., Hata, M., Ishiguro, M., Fujieda, H., Itoh, Y., Hirano, T., Nakagawa, H., Ogura, M., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800970b · Cited by 101
FFAR1 Is Involved in Both the Acute and Chronic Effects of Palmitate on Insulin Secretion
Kristinsson, H., Smith, D. M., Bergsten, P., & Sargsyan, E. (2013) · Endocrinology · doi:10.1210/en.2013-1352 · Cited by 101
Araki, T., Hirayama, M., Hiroi, S., & Kaku, K. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01525.x · Cited by 100
Inoue, D., Kimura, I., Wakabayashi, M., Tsumoto, H., Ozawa, K., Hara, T., Takei, Y., Hirasawa, A., Ishihama, Y., & Tsujimoto, G. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.04.021 · Cited by 99
Sasaki, S., Kitamura, S., Negoro, N., Suzuki, M., Tsujihata, Y., Suzuki, N., Santou, T., Kanzaki, N., Harada, M., Tanaka, Y., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101405t · Cited by 98
Tikhonova, I. G., Sum, C. S., Neumann, S., Thomas, C. J., Raaka, B. M., Costanzi, S., & Gershengorn, M. C. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm0614782 · Cited by 97
Treatment of Type 2 Diabetes by Free Fatty Acid Receptor Agonists
Watterson, K. R., Hudson, B. D., Ulven, T., & Milligan, G. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00137 · Cited by 97
Self-citationThe first synthetic agonists of FFA2: Discovery and SAR of phenylacetamides as allosteric modulators
Wang, Y., Jiao, X., Kayser, F., Liu, J., Wang, Z., Wanska, M., Greenberg, J., Weiszmann, J., Ge, H., Tian, H., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.112 · Cited by 96
Activation of FFA1 mediates GLP-1 secretion in mice. Evidence for allosterism at FFA1
Xiong, Y., Swaminath, G., Cao, Q., Li, Y., Guo, Q., Salomonis, H., Lu, J. Y.-L., Houze, J. B., Dransfield, P. J., Wang, Y., et al. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.01.009 · Cited by 96
Song, F., Lu, S., Gunnet, J., Xu, J., Wines, P., Proost, J. C., Liang, Y. T., Baumann, C., Lenhard, J., Murray, W. V., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm070130j · Cited by 96
Expression of odorant receptor Olfr78 in enteroendocrine cells of the colon
Fleischer, J., Bumbalo, R., Bautze, V., Strotmann, J. M., & Breer, H. (2015) · Cell and Tissue Research · doi:10.1007/s00441-015-2165-0 · Cited by 96
Hudson, B. D., Christiansen, E., Tikhonova, I. G., Grundmann, M., Kostenis, E., Adams, D. R., Ulven, T., & Milligan, G. (2012) · The FASEB Journal · doi:10.1096/fj.12-213314 · Cited by 96
Self-citationG protein-coupled receptor 120 signaling regulates ghrelin secretion in vivo and in vitro
Zhi, G., Yoshimura, M., Aizawa, S., Kurotani, R., Zigman, J. M., Sakai, T., & Sakata, I. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00306.2013 · Cited by 96
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1
Yabuki, C., Komatsu, H., Tsujihata, Y., Risa, M., Ito, R., Kae, M.-N., Sakuma, K., Miyawaki, K., Kikuchi, N., Takeuchi, K., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076280 · Cited by 95
Stoddart, L. A., Brown, A. J., & Milligan, G. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.031534 · Cited by 95
Self-citationMohr, K., Schmitz, J., Schrage, R., Tränkle, C., & Holzgrabe, U. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201205315 · Cited by 93
Discovery of AM-1638: A Potent and Orally Bioavailable GPR40/FFA1 Full Agonist
Brown, S. P., Dransfield, P. J., Vimolratana, M., Jiao, X., Zhu, L., Pattaropong, V., Sun, Y., Liu, J., Luo, J., Zhang, J., et al. (2012) · ACS Medicinal Chemistry Letters · doi:10.1021/ml300133f · Cited by 93
Li, X., Zhong, K., Guo, Z., Zhong, D., & Chen, X. (2015) · Drug Metabolism and Disposition · doi:10.1124/dmd.115.064121 · Cited by 92
Structure-Activity Relationships of GPR120 Agonists Based on a Docking Simulation
Sun, Q. L., Hirasawa, A., Hara, T., Kimura, I., Adachi, T., Awaji, T., Ishiguro, M., Suzuki, T., Miyata, N., & Tsujimoto, G. (2010) · Molecular Pharmacology · doi:10.1124/mol.110.066324 · Cited by 92
Structural insights into ligand recognition and selectivity for classes A, B, and C GPCRs
Lee, S. M., Booe, J. M., & Pioszak, A. A. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.05.013 · Cited by 92
Thiazolidinediones Induce Osteocyte Apoptosis by a G Protein-coupled Receptor 40-dependent Mechanism
Mieczkowska, A., Baslé, M. F., Chappard, D., & Mabilleau, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.324814 · Cited by 91
Nakamoto, K., Nishinaka, T., Sato, N., Mankura, M., Kōyama, Y., Kasuya, F., & Tokuyama, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081563 · Cited by 91
Leifke, E., Naik, H., Wu, J., Viswanathan, P., DeManno, D. A., Kipnes, M. S., & Vakilynejad, M. (2012) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.2012.43 · Cited by 91
Li, X., Yu, Y., & Funk, C. D. (2013) · The FASEB Journal · doi:10.1096/fj.13-235333 · Cited by 90
Burns, R. N., & Moniri, N. H. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.05.057 · Cited by 89
Naik, H., Vakilynejad, M., Wu, J., Viswanathan, P., Dote, N., Higuchi, T., & Leifke, E. (2011) · The Journal of Clinical Pharmacology · doi:10.1177/0091270011409230 · Cited by 88
Forbes, S. C., Stafford, S., Coope, G., Heffron, H., Real, K., Newman, R., Davenport, R., Barnes, M., Grosse, J., & Cox, H. M. (2015) · Diabetes · doi:10.2337/db15-0481 · Cited by 87
Bias in chemokine receptor signalling
Zweemer, A. J. M., Toraskar, J., Heitman, L. H., & IJzerman, A. P. (2014) · Trends in Immunology · doi:10.1016/j.it.2014.02.004 · Cited by 87
Smith, N. J., Ward, R. J., Stoddart, L. A., Hudson, B. D., Kostenis, E., Ulven, T., Morris, J. C., Tränkle, C., Tikhonova, I. G., Adams, D. R., et al. (2011) · Molecular Pharmacology · doi:10.1124/mol.110.070789 · Cited by 86
Self-citationFrom G Protein-coupled Receptor Structure Resolution to Rational Drug Design
Jazayeri, A., Dias, J. M., & Marshall, F. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.668251 · Cited by 85
The Action and Mode of Binding of Thiazolidinedione Ligands at Free Fatty Acid Receptor 1
Smith, N. J., Stoddart, L. A., Devine, N. M., Jenkins, L., & Milligan, G. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.012849 · Cited by 85
Self-citationRuminant and industrial sources of trans-fat and cardiovascular and diabetic diseases
Tardy, A.-L., Morio, B., Chardigny, J., & Malpuech‐Brugère, C. (2011) · Nutrition Research Reviews · doi:10.1017/s0954422411000011 · Cited by 85
Negoro, N., Sasaki, S., Mikami, S., Ito, M., Tsujihata, Y., Ito, R., Suzuki, M., Takeuchi, K., Suzuki, N., Miyazaki, J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300170m · Cited by 85
Yashiro, H., Tsujihata, Y., Takeuchi, K., Hazama, M., Johnson, P. R. V., & Rorsman, P. (2012) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.187708 · Cited by 84
The Role of G-Protein Receptor 84 in Experimental Neuropathic Pain
Nicol, L. S. C., Dawes, J. M., Russa, F. L., Didangelos, A., Clark, A. K., Gentry, C., Grist, J., Davies, J. B., Malcangio, M., & McMahon, S. B. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.3558-14.2015 · Cited by 81
Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3
Milligan, G., Stoddart, L. A., & Smith, N. J. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00421.x · Cited by 80
Self-citationPerspectives on the therapeutic potential of short-chain fatty acid receptors
Kim, S., Kim, J., Park, B. O., & Kwak, Y. S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.3.272 · Cited by 77
Müller, C. E., Schiedel, A. C., & Baqi, Y. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.06.002 · Cited by 76
Davie, B. J., Christopoulos, A., & Scammells, P. J. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400086m · Cited by 76
Wagner, R. J., Kaiser, G., Gerst, F., Christiansen, E., Due‐Hansen, M. E., Grundmann, M., Machicao, F. E., Peter, A., Kostenis, E., Ulven, T., et al. (2013) · Diabetes · doi:10.2337/db12-1249 · Cited by 76
Self-citationBjursell, M., Xu, X., Admyre, T., Böttcher, G., Lundin, S., Nilsson, R. G., Stone, V. M., Morgan, N. G., Lam, Y. Y., Storlien, L. H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114942 · Cited by 75
Fujita, T., Matsuoka, T., Honda, T., Kabashima, K., Hirata, T., & Narumiya, S. (2011) · Journal of Investigative Dermatology · doi:10.1038/jid.2011.123 · Cited by 75
Christiansen, E., Hansen, S. V. F., Urban, C., Hudson, B. D., Wargent, E. T., Grundmann, M., Jenkins, L., Zaibi, M. S., Stocker, C. J., Ullrich, S., et al. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml4000673 · Cited by 74
Self-citationThe Molecular Basis of Ligand Interaction at Free Fatty Acid Receptor 4 (FFA4/GPR120)
Hudson, B. D., Shimpukade, B., Milligan, G., & Ulven, T. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.561449 · Cited by 72
Self-citationMilligan, G., Alvarez‐Curto, E., Watterson, K. R., Ulven, T., & Hudson, B. D. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12879 · Cited by 71
Self-citationComplex Pharmacology of Novel Allosteric Free Fatty Acid 3 Receptor Ligands
Hudson, B. D., Christiansen, E., Murdoch, H., Jenkins, L., Hansen, A. H., Madsen, O., Ulven, T., & Milligan, G. (2014) · Molecular Pharmacology · doi:10.1124/mol.114.093294 · Cited by 71
Self-citationEgerod, K. L., Engelstoft, M. S., Lund, M. L., Grunddal, K. V., Zhao, M., Barir-Jensen, D., Nygaard, E. B., Petersen, N., Holst, J. J., & Schwartz, T. W. (2015) · Endocrinology · doi:10.1210/en.2015-1388 · Cited by 70
Sokol, E., Ulven, T., Færgeman, N. J., & Ejsing, C. S. (2015) · European Journal of Lipid Science and Technology · doi:10.1002/ejlt.201400575 · Cited by 70
Self-citationNatalicchio, A., Labarbuta, R., Tortosa, F., Biondi, G., Marrano, N., Peschechera, A., Carchia, E., Orlando, M. R., Leonardini, A., Cignarelli, A., et al. (2013) · Diabetologia · doi:10.1007/s00125-013-3028-4 · Cited by 70
Hasan, A. U., Ohmori, K., Konishi, K., Igarashi, J., Hashimoto, T., Kamitori, K., Yamaguchi, F., Tsukamoto, I., Uyama, T., Ishihara, Y., et al. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.02.012 · Cited by 68
Moore, K., Zhang, Q., Murgolo, N., Hosted, T., & Duffy, R. A. (2009) · Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology · doi:10.1016/j.cbpb.2009.08.005 · Cited by 68
Moran, B. M., Abdel‐Wahab, Y. H. A., Flatt, P. R., & McKillop, A. M. (2014) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12330 · Cited by 67
A novel class of antagonists for the FFAs receptor GPR40
Hu, H., He, L. Y., Gong, Z. L., Li, N., Lu, Y., Zhai, Q. W., Liu, H., Jiang, H. L., Zhu, W., & Wang, H. Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.10.004 · Cited by 66
Identification of surrogate ligands for orphan G protein-coupled receptors
Takeda, S., Yamamoto, A., Okada, T., 松村, 恵., Nose, E., Kogure, K., Kojima, S., & Haga, T. (2003) · Life Sciences · doi:10.1016/j.lfs.2003.09.030 · Cited by 65
Audoy-Rémus, J., Bozoyan, L., Dumas, A., Filali, M., Lecours, C., Lacroix, S., Rivest, S., Tremblay, M., & Vallières, L. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.01.010 · Cited by 65
Butcher, A. J., Hudson, B. D., Shimpukade, B., Alvarez‐Curto, E., Prihandoko, R., Ulven, T., Milligan, G., & Tobin, A. B. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.568816 · Cited by 64
Self-citationPaulsen, S. J., Larsen, L. K., Hansen, G., Chelur, S., Larsen, P. J., & Vrang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088227 · Cited by 64
Christiansen, E., Due‐Hansen, M. E., Urban, C., Merten, N., Pfleiderer, M. I. B., Karlsen, K. K., Rasmussen, S., Steensgaard, M., Hamacher, A., Schmidt, J., et al. (2010) · ACS Medicinal Chemistry Letters · doi:10.1021/ml100106c · Cited by 64
Self-citationBurns, R. N., Singh, M., Senatorov, I. S., & Moniri, N. H. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.016 · Cited by 62
Cranmer-Byng, M., Liddle, D. M., Boer, A. A. D., Monk, J. M., & Robinson, L. E. (2014) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2014-0022 · Cited by 62
Prihandoko, R., Alvarez‐Curto, E., Hudson, B. D., Butcher, A. J., Ulven, T., Miller, A. M., Tobin, A. B., & Milligan, G. (2016) · Molecular Pharmacology · doi:10.1124/mol.115.101949 · Cited by 62
Self-citationSchmidt, J., Liebscher, K., Merten, N., Grundmann, M., Mielenz, M., Sauerwein, H., Christiansen, E., Due‐Hansen, M. E., Ulven, T., Ullrich, S., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.200477 · Cited by 60
Self-citationTwo Arginine-Glutamate Ionic Locks Near the Extracellular Surface of FFAR1 Gate Receptor Activation
Sum, C. S., Tikhonova, I. G., Costanzi, S., & Gershengorn, M. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806987200 · Cited by 60
Little, T. J., Isaacs, N. J., Young, R. L., Ott, R., Nguyen, N. Q., Rayner, C. K., Horowitz, M., & Feinle‐Bisset, C. (2014) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00134.2014 · Cited by 59
ElAzzouny, M. A., Evans, C. R., Treutelaar, M. K., Kennedy, R. T., & Burant, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.531970 · Cited by 59
Evaluation of the relationship between GPR43 and adiposity in human
Dewulf, E. M., Ge, Q., Bindels, L. B., Sohet, F. M., Cani, P. D., Brichard, S. M., & Delzenne, N. M. (2013) · Nutrition & Metabolism · doi:10.1186/1743-7075-10-11 · Cited by 59
Christiansen, E., Due‐Hansen, M. E., Urban, C., Grundmann, M., Schmidt, J., Hansen, S. V. F., Hudson, B. D., Zaibi, M. S., Markussen, S. B., Hagesæther, E., et al. (2013) · Journal of Medicinal Chemistry · doi:10.1021/jm301470a · Cited by 59
Self-citationChristiansen, E., Due‐Hansen, M. E., Urban, C., Grundmann, M., Schröder, R. J., Hudson, B. D., Milligan, G., Cawthorne, M. A., Kostenis, E., Kassack, M. U., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm3002026 · Cited by 58
Self-citationWang, L., Zhao, Y., Gui, B., Fu, R., Ma, F., Yu, J. M., Qü, P., Dong, L., & Chen, C. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0132 · Cited by 58
Daenen, L. G. M., Cirkel, G. A., Houthuijzen, J. M., Gerrits, J., Oosterom, I., Roodhart, J. M. L., van Tinteren, H., Ishihara, K., Huitema, A. D. R., Verhoeven‐Duif, N. M., et al. (2015) · JAMA Oncology · doi:10.1001/jamaoncol.2015.0388 · Cited by 58
Mizuta, K., Zhang, Y., Mizuta, F., Hoshijima, H., Shiga, T., Masaki, E., & Emala, C. W. (2015) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2015 · Cited by 58
Hill, S. J., May, L. T., Kellam, B., & Woolard, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12345 · Cited by 57
Discovery of 5-aryloxy-2,4-thiazolidinediones as potent GPR40 agonists
Zhou, C., Tang, C., Chang, E., Ge, M., Lin, S., Cline, E., Tan, C. P., Feng, Y., Zhou, Y., Eiermann, G. J., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.10.052 · Cited by 56
Boatman, P. D., Lauring, B. P., Schrader, T. O., Kasem, M., Johnson, B. R. G., Skinner, P. J., Jung, J., Xu, J., Cherrier, M. C., Webb, P. J., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm2010964 · Cited by 54
Selective novel inverse agonists for human GPR43 augment GLP-1 secretion
Park, B.-O., Kim, S. H., Kong, G. Y., Kim, D. H., Kwon, M. S., Lee, S. U., Kim, M.-O., Cho, S., Lee, S., Lee, H., et al. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.12.010 · Cited by 54
Schann, S., Mayer, S., Franchet, C., Frauli, M., Steinberg, E., Thomas, M., Baron, L., & Neuville, P. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm101069m · Cited by 54
Hudson, B. D., Smith, N. J., & Milligan, G. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00006-3 · Cited by 53
Self-citationInsights into the Roles of Gut Microbes in Obesity
Sanz, Y., Santacruz, A., & Palma, G. D. (2008) · Interdisciplinary Perspectives on Infectious Diseases · doi:10.1155/2008/829101 · Cited by 53
Ice breaking in GPCR structural biology
Zhao, Q., & Wu, B. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.187 · Cited by 53
Inhibition of GPR40 protects MIN6 β cells from palmitate‐induced ER stress and apoptosis
Wu, J., Sun, P. G., Zhang, X., Liu, H., Jiang, H., Zhu, W., & Wang, H. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23450 · Cited by 53
Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer
Christiansen, E., Hudson, B. D., Hansen, A. H., Milligan, G., & Ulven, T. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00202 · Cited by 53
Self-citationHumphries, P. S., Benbow, J. W., Bonin, P. D., Boyer, D. D., Doran, S. D., Frisbie, R. K., Piotrowski, D. W., Balan, G., Bechle, B. M., Conn, E. L., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.03.082 · Cited by 52
Tsukahara, T., Watanabe, K., Watanabe, T., Yamagami, H., Sogawa, M., Tanigawa, T., Shiba, M., Tominaga, K., Fujiwara, Y., Maeda, K., et al. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2014.09.010 · Cited by 51
Drug Design for G‐Protein‐Coupled Receptors by a Ligand‐Based NMR Method
Bartoschek, S., Klabunde, T., Defoßa, E., Dietrich, V., Stengelin, S., Griesinger, C., Carlomagno, T., Focken, I., & Wendt, K. U. (2010) · Angewandte Chemie International Edition · doi:10.1002/anie.200905102 · Cited by 51
Frolov, A., Yang, L., Dong, H., Hammock, B. D., & Crofford, L. J. (2013) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2013.08.003 · Cited by 50
Heterodimers and family-B GPCRs: RAMPs, CGRP and adrenomedullin
Conner, A. C., Simms, J., Hay, D. L., Mahmoud, K., Howitt, S. G., Wheatley, M., & Poyner, D. R. (2004) · Biochemical Society Transactions · doi:10.1042/bst0320843 · Cited by 50
Effects of obesity/fatty acids on the expression of GPR120
Rodríguez‐Pacheco, F., García‐Serrano, S., García‐Escobar, E., Gutiérrez‐Repiso, C., García-Arnés, J. A., Valdés, S., Gonzalo, M., Soriguer, F., Moreno‐Ruiz, F. J., Rodríguez‐Cañete, A., et al. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201300666 · Cited by 50
GPR120 agonism as a countermeasure against metabolic diseases
Cornall, L. M., Mathai, M. L., Hryciw, D. H., & McAinch, A. J. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.11.021 · Cited by 50
Zhang, Q., Yang, H., Li, J. X., & Xie, X. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232033 · Cited by 50
G Protein-coupled Receptor 40 (GPR40) and Peroxisome Proliferator-activated Receptor γ (PPARγ)
Wang, S., Awad, K. S., Elinoff, J. M., Dougherty, E. J., Ferreyra, G. A., Wang, J. Y., Cai, R., Sun, J., Ptasinska, A., & Danner, R. L. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.638924 · Cited by 49
Brownlie, R., Mayers, R. M., Pierce, J. A., Marley, A. E., & Smith, D. M. (2008) · Biochemical Society Transactions · doi:10.1042/bst0360950 · Cited by 49
Qian, J., Wu, C. J., Chen, X., Li, X., Ying, G., Jin, L., Ma, Q., Guo, L., Shi, Y., Zhang, G., et al. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.07.019 · Cited by 48
Gras, D., Chanez, P., Urbach, V., Vachier, I., Godard, P., & Bonnans, C. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.90219.2008 · Cited by 48
Fukushima, K., Yamasaki, E., Ishii, S., Tomimatsu, A., Takahashi, K., Hirane, M., Fukushima, N., Honoki, K., & Tsujiuchi, T. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.050 · Cited by 47
Sun, P. G., Wang, T., Zhou, Y., Liu, H., Jiang, H., Zhu, W., & Wang, H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066744 · Cited by 47
Flow Cytometry-Based Binding Assay for GPR40 (FFAR1; Free Fatty Acid Receptor 1)
Hara, T., Hirasawa, A., Sun, Q., Koshimizu, T., Itsubo, C., Sadakane, K., Awaji, T., & Tsujimoto, G. (2008) · Molecular Pharmacology · doi:10.1124/mol.108.052225 · Cited by 47
Kim, N., Lee, J. O., Lee, H. J., Kim, H. I., Kim, J. K., Lee, S. K., Lee, S. K., Kim, S. J., Park, S. H., & Kim, H. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.657379 · Cited by 47
Sergeev, E., Hansen, A. H., Pandey, S. K., Mackenzie, A. E., Hudson, B. D., Ulven, T., & Milligan, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.687939 · Cited by 47
Self-citationOnaran, H. O., Rajagopal, S., & Costa, T. (2014) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2014.09.010 · Cited by 44
Zhang, X., Yan, G., Li, Y., Zhu, W., & Wang, H. (2010) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2010.06.008 · Cited by 44
Karki, P., Kurihara, T., Nakamachi, T., Watanabe, J., Asada, T., Oyoshi, T., Shioda, S., Yoshimura, M., Arita, K., & Miyata, A. (2015) · Molecular Pain · doi:10.1186/s12990-015-0003-8 · Cited by 44
G protein–coupled receptor modulation with pepducins: moving closer to the clinic
Dimond, P. F., Carlson, K. E., Bouvier, M., Gerard, C. J., Xu, L., Covic, L., Agarwal, A., Ernst, O. P., Janz, J. M., Schwartz, T. W., et al. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06039.x · Cited by 43
Self-citationKim, H., Yoon, H., Kim, B. K., Kang, W. Y., Seong, S. J., Lim, M., Kim, S., & Yoon, Y. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25133 · Cited by 42
Mutation analysis and molecular modeling for the investigation of ligand-binding modes of GPR84
Nikaido, Y., Koyama, Y., Yoshikawa, Y., Furuya, T., & Takeda, S. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu075 · Cited by 42
Chao, C., Lii, C., Ye, S.-Y., Li, C., Lu, C., Lin, A., Liu, K., & Chen, H. (2014) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf5007165 · Cited by 42
G-protein-coupled receptors for free fatty acids: nutritional and therapeutic targets
Milligan, G., Ulven, T., Murdoch, H., & Hudson, B. D. (2014) · British Journal Of Nutrition · doi:10.1017/s0007114513002249 · Cited by 42
Self-citationTanaka, H., Yoshida, S., Minoura, H., Negoro, K., Shimaya, A., Shimokawa, T., & Shibasaki, M. (2013) · Life Sciences · doi:10.1016/j.lfs.2013.11.010 · Cited by 41
Ancel, D., Bernard, A., Selvakumar, S., Hirasawa, A., Tsujimoto, G., Hashimoto, T., Passilly‐Degrace, P., Khan, N.-A., & Besnard, P. (2014) · Journal of Lipid Research · doi:10.1194/jlr.m055202 · Cited by 41
Free Fatty Acid Receptor GPR120 and Pathogenesis of Obesity and Type 2 Diabetes Mellitus
Mo, X., Wei, H., Peng, J., & Tao, Y. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-386933-3.00007-8 · Cited by 38
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health
Yamashima, T. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.01.002 · Cited by 38
Fredborg, M., Theil, P. K., Jensen, B. B., & Purup, S. (2012) · Journal of Animal Science · doi:10.2527/jas.53792 · Cited by 38
Discovery of DS-1558: A Potent and Orally Bioavailable GPR40 Agonist
Takano, R., Yoshida, M., Inoue, M., Honda, T., Nakashima, R., Matsumoto, K., Yano, T., Ogata, T., Watanabe, N., Hirouchi, M., et al. (2015) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500391n · Cited by 37
Bozoyan, L., Audoy-Rémus, J., Dumas, A., Filali, M., Lacroix, S., Rivest, S., Tremblay, M., & Vallières, L. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.08.351 · Cited by 37
The therapeutic potential of GPR120: a patent review
Halder, S., Kumar, S., & Sharma, R. K. (2013) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.2013.842977 · Cited by 37
Minireview: The Effects of Species Ortholog and SNP Variation on Receptors for Free Fatty Acids
Hudson, B. D., Murdoch, H., & Milligan, G. (2013) · Molecular Endocrinology · doi:10.1210/me.2013-1085 · Cited by 37
Self-citationA Molecular Mechanism for Sequential Activation of a G Protein-Coupled Receptor
Grundmann, M., Tikhonova, I. G., Hudson, B. D., Smith, N. J., Mohr, K., Ulven, T., Milligan, G., Kenakin, T., & Kostenis, E. (2016) · Cell chemical biology · doi:10.1016/j.chembiol.2016.02.014 · Cited by 37
Self-citationPepducins and Other Lipidated Peptides as Mechanistic Probes and Therapeutics
Zhang, P., Covic, L., & Kuliopulos, A. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2806-4_13 · Cited by 37
Lipidomics in drug development
Dehairs, J., Derua, R., Rueda-Rincón, N., & Swinnen, J. V. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.03.002 · Cited by 36
Dranse, H. J., Kelly, M. E. M., & Hudson, B. D. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12327 · Cited by 35
Self-citationSequence Polymorphisms Provide a Common Consensus Sequence for GPR41 and GPR42
Liaw, C. W., & Connolly, D. T. (2009) · DNA and Cell Biology · doi:10.1089/dna.2009.0916 · Cited by 35
Zahanich, I., Kondratov, I. S., Naumchyk, V., Kheylik, Y. P., Platonov, M. O., Zozulya, S., & Krasavin, M. (2015) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2015.06.018 · Cited by 34
Konno, Y., Ueki, S., Takeda, M., Kobayashi, Y., Tamaki, M., Moritoki, Y., Oyamada, H., Itoga, M., Kayaba, H., Omokawa, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120386 · Cited by 34
Puhl, H. L., Won, Y., Lu, V. B., & Ikeda, S. R. (2015) · Scientific Reports · doi:10.1038/srep12880 · Cited by 34
Panse, M., Gerst, F., Kaiser, G., Teutsch, C.-A., Dölker, R., Wagner, R. J., Häring, H., & Ullrich, S. (2015) · Cellular Physiology and Biochemistry · doi:10.1159/000373969 · Cited by 33
Alquier, T., & Poitout, V. (2009) · Diabetes · doi:10.2337/db09-0215 · Cited by 33
Bonnefond, A., Lamri, A., Leloire, A., Vaillant, E., Roussel, R., Lévy‐Marchal, C., Weill, J., Galan, P., Herçberg, S., Ragot, S., et al. (2015) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103065 · Cited by 32
Functional studies cast light on receptor states
Ehlert, F. J. (2015) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2015.05.008 · Cited by 30
G‐protein‐coupled receptor structures were not built in a day
Blois, T. M., & Bowie, J. U. (2009) · Protein Science · doi:10.1002/pro.165 · Cited by 30
FFA1‐selective agonistic activity based on docking simulation using FFA1 and GPR120 homology models
Takeuchi, M., Hirasawa, A., Hara, T., Kimura, I., Hirano, T., Suzuki, T., Miyata, N., Awaji, T., Ishiguro, M., & Tsujimoto, G. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02052.x · Cited by 28
Vestmar, M. A., Galijatovic, E. A. A., Christensen, C. R., Hauge, M., Glümer, C., Linneberg, A. R., Witte, D. R., Jørgensen, M. E., Christensen, C., Brandslund, I., et al. (2016) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2015-103728 · Cited by 28
Shen, X., Yang, L., Yan, S., Wei, W., Liang, L., Zheng, H., & Cai, X. (2013) · Metabolism · doi:10.1016/j.metabol.2013.11.003 · Cited by 27
Discovery of SCH 900271, a Potent Nicotinic Acid Receptor Agonist for the Treatment of Dyslipidemia
Palani, A., Rao, A. U., Chen, X., Huang, X., Su, J., Tang, H., Huang, Y. R., Qin, J., Xiao, D., Degrado, S. J., et al. (2011) · ACS Medicinal Chemistry Letters · doi:10.1021/ml200243g · Cited by 27
The Therapeutic Potential of Allosteric Ligands for Free Fatty Acid Sensitive GPCRs
Hudson, B. D., Ulven, T., & Milligan, G. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026611313010004 · Cited by 27
Self-citationShen, H. C., Taggart, A. K. P., Wilsie, L. C., Waters, M. G., Hammond, M. L., Tata, J. R., & Colletti, S. L. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.039 · Cited by 24
Discovery of Novel FFA4 (GPR120) Receptor Agonists with β-Arrestin2-Biased Characteristics
Li, A., Yang, D., Zhu, M., Tsai, K., Xiao, K., Yu, X., Sun, J., & Du, L. (2015) · Future Medicinal Chemistry · doi:10.4155/fmc.15.160 · Cited by 23
Comparing the Molecular Pharmacology of CGRP and Adrenomedullin
Woolley, M. J., & Conner, A. C. (2013) · Current Protein and Peptide Science · doi:10.2174/13892037113149990053 · Cited by 22
Trayhurn, P., & Denyer, G. S. (2012) · Journal of Nutritional Science · doi:10.1017/jns.2012.3 · Cited by 21
Perez, C. J., Dumas, A., Vallières, L., Guénet, J., & Benavides, F. J. (2013) · Journal of Heredity · doi:10.1093/jhered/est023 · Cited by 21
Free fatty acid receptor 3 is a key target of short chain fatty acid
Soto, E. J. L., Ongaro, L., & Mustafá, E. R. (2014) · Channels · doi:10.4161/chan.28956 · Cited by 21
Pharmacological properties of acid N‐thiazolylamide FFA 2 agonists
Brown, A. J., Tsoulou, C., Ward, E., Gower, E., Bhudia, N., Chowdhury, F., Dean, T. W., Faucher, N., Gangar, A., & Dowell, S. J. (2015) · Pharmacology Research & Perspectives · doi:10.1002/prp2.141 · Cited by 20
Physiology and Therapeutics of the Free Fatty Acid Receptor GPR40
Huang, H., Dai, M., & Tao, Y. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00003-x · Cited by 19
Ren, X., Cao, L.-Y., Zhang, J., Qin, W.-P., Yang, Y., Wan, B., & Guo, L. (2016) · Biochemistry · doi:10.1021/acs.biochem.6b00079 · Cited by 19
Bertrand, R., Wolf, A., Ivashchenko, Y., Löhn, M., Schäfer, M., Brönstrup, M., Gotthardt, M., Derdau, V., & Plettenburg, O. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00791 · Cited by 17
Tang, X., Wang, C.-N., Zhu, X., & Ni, X. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.013 · Cited by 15
Discovery of novel orally bioavailable GPR40 agonists
Lu, H., Fei, H., Yang, F., Zheng, S., Hu, Q., Zhang, L. J., Yuan, J., Feng, J., Sun, P., & Dong, Q. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.03.060 · Cited by 14
Constitutive Activity of GPR40/FFA1
Stoddart, L. A., & Milligan, G. (2010) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/b978-0-12-381298-8.00028-9 · Cited by 13
Self-citationMucus can change the permeation rank order of drug candidates
Hagesæther, E., Christiansen, E., Due‐Hansen, M. E., & Ulven, T. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.05.036 · Cited by 10
Self-citationContribution of the hypothalamus and gut to weight gain susceptibility and resistance in mice
Fam, B. C., Sgambellone, R., Ruan, Z., Proietto, J., & Andrikopoulos, S. (2015) · Journal of Endocrinology · doi:10.1530/joe-15-0131 · Cited by 8
Cited by
Free Fatty Acid Receptors in Health and Disease
Kimura, I., Ichimura, A., Ohue-Kitano, R., & Igarashi, M. (2020) · Physiological Reviews · doi:10.1152/physrev.00041.2018 · Cited by 1,018
van de Wouw, M., Boehme, M., Lyte, J. M., Wiley, N., Strain, C., O'Sullivan, O., Clarke, G., Stanton, C., Dinan, T. G., & Cryan, J. F. (2018) · The Journal of Physiology · doi:10.1113/jp276431 · Cited by 789
“, 2016), Gprotein couple receptors (GPCR) (Milligan et al., 2017), facilitating the secretion of various hormones (e.”
BackgroundInfluentialPathogenesis of autoimmune disease
Pisetsky, D. S. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00720-1 · Cited by 649
Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs)
Ratajczak, W., Rył, A., Mizerski, A., Walczakiewicz, K., Sipak, O., & Laszczyńska, M. (2019) · Acta Biochimica Polonica · doi:10.18388/abp.2018_2648 · Cited by 514
Sencio, V., Barthelemy, A., Tavares, L. P., Machado, M. G., Soulard, D., Cuinat, C., Queiroz-Junior, C. M., Noordine, M.-L., Salomé-Desnoulez, S., Deryuter, L., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.013 · Cited by 357
Self-citation
Metadata
- Authors
- Milligan, G., Shimpukade, B., Ulven, T., & Hudson, B. D.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2016-06-14
- Volume
- 117
- Issue
- 1
- Pages
- 67-110
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W2429754450
- Cited by
- 267
- References
- 380
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.